Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marit M Suttorp

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 18, 2014
Graphical presentation of confounding in directed acyclic graphsMarit M Suttorp, Bob Siegerink, Kitty J Jager, et al.
Plos One|January 7, 2014
Effect of erythropoiesis-stimulating agents on blood pressure in pre-dialysis patientsMarit M Suttorp, Tiny Hoekstra, Moshe Mittelman, et al.
Pharmacoepidemiology and Drug Safety|August 13, 2015
Treatment with high dose of erythropoiesis-stimulating agents and mortality: analysis with a sequential Cox approach and a marginal structural modelMarit M Suttorp, Tiny Hoekstra, Moshe Mittelman, et al.
BMC Nephrology|September 27, 2013
Erythropoiesis-stimulating agent resistance and mortality in hemodialysis and peritoneal dialysis patientsMarit M Suttorp, Tiny Hoekstra, Joris I Rotmans, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 6, 2015
Trends in haemoglobin, erythropoietin-stimulating agents and iron use in Swedish chronic kidney disease patients between 2008 and 2013Marie Evans, Marit M Suttorp, Rino Bellocco, et al.
Thrombosis Journal|September 18, 2014
The influence of Erythropoietin on platelet activation, thrombin generation and FVII/active FVII in patients with AMIGabriele Demetz, Magdalena Laux, Armin Scherhag, et al.
Clinical Epidemiology|October 13, 2018
Erythropoiesis-stimulating agents and cardiovascular events in patients with myelodysplastic syndrome and multiple myelomaErzsébet Horváth-Puhó, Marit M Suttorp, Henrik Frederiksen, et al.
Thrombosis Research|September 23, 2014
Erythropoiesis-stimulating agents and thrombotic events in dialysis patientsMarit M Suttorp, Tiny Hoekstra, Gürbey Ocak, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 30, 2014
The association between dialysis modality and the risk for dialysis technique and non-dialysis technique-related infectionsAnouk T N van Diepen, Tiny Hoekstra, Joris I Rotmans, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 27, 2009
Association between busulfan exposure and outcome in children receiving intravenous busulfan before hematologic stem cell transplantationImke H Bartelink, Robert G M Bredius, Svetlana V Belitser, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 18, 2014
Graphical presentation of confounding in directed acyclic graphsMarit M Suttorp, Bob Siegerink, Kitty J Jager, et al.
Plos One|January 7, 2014
Effect of erythropoiesis-stimulating agents on blood pressure in pre-dialysis patientsMarit M Suttorp, Tiny Hoekstra, Moshe Mittelman, et al.
Pharmacoepidemiology and Drug Safety|August 13, 2015
Treatment with high dose of erythropoiesis-stimulating agents and mortality: analysis with a sequential Cox approach and a marginal structural modelMarit M Suttorp, Tiny Hoekstra, Moshe Mittelman, et al.
BMC Nephrology|September 27, 2013
Erythropoiesis-stimulating agent resistance and mortality in hemodialysis and peritoneal dialysis patientsMarit M Suttorp, Tiny Hoekstra, Joris I Rotmans, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 6, 2015
Trends in haemoglobin, erythropoietin-stimulating agents and iron use in Swedish chronic kidney disease patients between 2008 and 2013Marie Evans, Marit M Suttorp, Rino Bellocco, et al.
Thrombosis Journal|September 18, 2014
The influence of Erythropoietin on platelet activation, thrombin generation and FVII/active FVII in patients with AMIGabriele Demetz, Magdalena Laux, Armin Scherhag, et al.
Clinical Epidemiology|October 13, 2018
Erythropoiesis-stimulating agents and cardiovascular events in patients with myelodysplastic syndrome and multiple myelomaErzsébet Horváth-Puhó, Marit M Suttorp, Henrik Frederiksen, et al.
Thrombosis Research|September 23, 2014
Erythropoiesis-stimulating agents and thrombotic events in dialysis patientsMarit M Suttorp, Tiny Hoekstra, Gürbey Ocak, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 30, 2014
The association between dialysis modality and the risk for dialysis technique and non-dialysis technique-related infectionsAnouk T N van Diepen, Tiny Hoekstra, Joris I Rotmans, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 27, 2009
Association between busulfan exposure and outcome in children receiving intravenous busulfan before hematologic stem cell transplantationImke H Bartelink, Robert G M Bredius, Svetlana V Belitser, et al.
Pageof 1